Multi-Ingredient Hydrocodone Drugs Proposed for Transfer to Schedule II
March 7, 2014 at 12:11:00 ET
The U.S. Drug Enforcement Administration proposed to transfer hydrocodone combination products (HCPs) from Schedule III to Schedule II based on recommendations of the Food and Drug Administration (79 Fed. Reg. 11037). HCPs are prescription drugs that contain specified doses of hydrocodone in combination with other drugs for treatment of moderate to severe pain and for cough suppre... Read More
